Group One Trading
VRTX icon

Group One Trading’s Vertex Pharmaceuticals VRTX Stock Holding History

Group One Trading’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.2M Sell
40,800
-22,200
-35% -$10.4M 0.03% 536
2025
Q4 		$28.6M Buy
63,000
+8,600
+16% +$3.71M 0.05% 368
2025
Q3 		$21.3M Sell
54,400
-27,800
-34% -$11.6M 0.04% 470
2025
Q2 		$36.6M Buy
82,200
+6,600
+9% +$3.04M 0.08% 224
2025
Q1 		$36.7M Buy
75,600
+800
+1% +$373K 0.11% 150
2024
Q4 		$30.1M Sell
74,800
-900
-1% -$417K 0.07% 246
2024
Q3 		$35.2M Buy
75,700
+34,900
+86% +$16.8M 0.1% 149
2024
Q2 		$19.1M Sell
40,800
-72,100
-64% -$31.3M 0.07% 213
2024
Q1 		$47.2M Sell
112,900
-35,900
-24% -$15.2M 0.18% 67
2023
Q4 		$60.5M Buy
148,800
+49,400
+50% +$18.2M 0.16% 78
2023
Q3 		$34.6M Buy
99,400
+22,800
+30% +$7.97M 0.12% 113
2023
Q2 		$27M Buy
76,600
+2,500
+3% +$842K 0.09% 161
2023
Q1 		$23.3M Sell
74,100
-2,100
-3% -$630K 0.08% 179
2022
Q4 		$22M Sell
76,200
-2,400
-3% -$731K 0.05% 366
2022
Q3 		$22.8M Sell
78,600
-57,400
-42% -$16.5M 0.04% 336
2022
Q2 		$38.3M Sell
136,000
-17,800
-12% -$4.76M 0.06% 254
2022
Q1 		$40.1M Buy
153,800
+26,300
+21% +$6.24M 0.04% 319
2021
Q4 		$28M Sell
127,500
-31,900
-20% -$6.2M 0.02% 516
2021
Q3 		$28.9M Sell
159,400
-74,100
-32% -$14.5M 0.03% 446
2021
Q2 		$47.1M Buy
233,500
+64,600
+38% +$13.5M 0.06% 267
2021
Q1 		$36.3M Buy
168,900
+38,000
+29% +$8.35M 0.05% 315
2020
Q4 		$30.9M Buy
130,900
+73,100
+126% +$16.8M 0.05% 301
2020
Q3 		$15.7M Buy
57,800
+1,800
+3% +$497K 0.05% 355
2020
Q2 		$16.3M Buy
56,000
+23,500
+72% +$6.37M 0.08% 282
2020
Q1 		$7.73M Sell
32,500
-17,700
-35% -$4.06M 0.06% 339
2019
Q4 		$11M Sell
50,200
-15,300
-23% -$3.1M 0.07% 314
2019
Q3 		$11.1M Buy
65,500
+23,300
+55% +$4.12M 0.09% 242
2019
Q2 		$7.74M Sell
42,200
-14,300
-25% -$2.5M 0.07% 330
2019
Q1 		$10.4M Sell
56,500
-16,100
-22% -$2.97M 0.12% 187
2018
Q4 		$12M Sell
72,600
-81,300
-53% -$14.1M 0.1% 194
2018
Q3 		$29.7M Buy
153,900
+67,900
+79% +$12.1M 0.23% 64
2018
Q2 		$14.6M Sell
86,000
-8,100
-9% -$1.26M 0.13% 162
2018
Q1 		$15.3M Buy
94,100
+65,300
+227% +$10.7M 0.15% 123
2017
Q4 		$4.32M Sell
28,800
-156,000
-84% -$23.1M 0.03% 711
2017
Q3 		$28.1M Buy
184,800
+117,700
+175% +$17.7M 0.26% 64
2017
Q2 		$8.65M Sell
67,100
-2,000
-3% -$241K 0.09% 243
2017
Q1 		$7.56M Buy
69,100
+32,800
+90% +$2.89M 0.09% 260
2016
Q4 		$2.67M Buy
36,300
+6,800
+23% +$553K 0.03% 760
2016
Q3 		$2.57M Hold
29,500
– – 0.03% 712
2016
Q2 		$2.54M Sell
29,500
-8,800
-23% -$760K 0.03% 682
2016
Q1 		$3.04M Sell
38,300
-13,600
-26% -$1.23M 0.04% 562
2015
Q4 		$6.53M Buy
51,900
+10,600
+26% +$1.28M 0.08% 271
2015
Q3 		$4.3M Buy
41,300
+19,400
+89% +$2.49M 0.06% 400
2015
Q2 		$2.7M Sell
21,900
-3,400
-13% -$428K 0.04% 576
2015
Q1 		$2.98M Sell
25,300
-49,700
-66% -$5.95M 0.05% 454
2014
Q4 		$8.91M Buy
75,000
+8,100
+12% +$912K 0.13% 146
2014
Q3 		$7.51M Sell
66,900
-43,400
-39% -$4.13M 0.12% 183
2014
Q2 		$10.4M Buy
110,300
+39,700
+56% +$2.78M 0.16% 115
2014
Q1 		$4.99M Sell
70,600
-26,100
-27% -$2.07M 0.08% 225
2013
Q4 		$7.18M Buy
96,700
+57,300
+145% +$3.99M 0.11% 172
2013
Q3 		$2.99M Sell
39,400
-41,400
-51% -$3.29M 0.06% 372
2013
Q2 		$6.45M Buy
+80,800
New +$5.95M 0.16% 121

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Group One Trading's VRTX Position: Q1 2026 in Review

Group One Trading opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 9,357 shares worth $4.18M. The stake represents 0.01% of the portfolio and ranks #1444 among its holdings. This is a return to the name: Group One Trading previously reported a position in VRTX as recently as Q3 2025.

Group One Trading first reported a position in VRTX in Q2 2013 and has held it in 32 quarters since. The position peaked at $23.5M in Q4 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Group One Trading held 9,357 shares of Vertex Pharmaceuticals worth $4.18M as of Q1 2026.
  • Vertex Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1444 holding.
  • Group One Trading first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
  • Group One Trading's Vertex Pharmaceuticals position peaked at $23.5M in Q4 2020.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.